|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating costs: | |||
| General and administrative expenses | |||
| Related party travel costs | |||
| Research and development expenses | |||
| Total operating costs | |||
| Interest income (expense), net | |||
| Other income (expense): | |||
| Interest income | |||
| Other expense | |||
| Unrealized loss on short-term investment | |||
| Total other income, net | |||
| Net Loss | |||
| Deemed dividend | |||
| Net loss attributable to common stockholders | |||
| Basic loss per share | |||
| Diluted loss per share | |||
| Basic weighted average common stock shares outstanding |
Loading...
